Literature DB >> 3088217

Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy.

H P Vogel, R Ketsche.   

Abstract

Thirteen drug-free and not severely affected patients with idiopathic Parkinson's disease underwent an insulin-hypoglycaemia test, a TRH test and a levodopa test. The responses of growth hormone, prolactin, cortisol and thyrotropin were measured, and retested under stable therapy with levodopa and benserazide. Mean basal and stimulated hormonal concentrations were in the normal range before and during therapy. Minor abnormalities were observed in individual cases, but did not indicate a hypothalamic dopamine deficit.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088217     DOI: 10.1007/bf00314421

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

1.  Corticosteroid and growth hormone secretion in patients treated with L-dopa.

Authors:  K von Werder; G R van Loon; F Yatsu; P H Forsham
Journal:  Klin Wochenschr       Date:  1970-12-15

2.  Blood levels of FSH, LH, TSH, and GH in parkinsonian patients before and during L-dopa treatment.

Authors:  P O Lundberg
Journal:  Acta Neurol Scand       Date:  1972       Impact factor: 3.209

3.  Stimulation of human-growth-hormone secretion by L-dopa.

Authors:  A E Boyd; H E Lebovitz; J B Pfeiffer
Journal:  N Engl J Med       Date:  1970-12-24       Impact factor: 91.245

4.  The effect of L-DOPA on the hypothalamic-pituitary-thyroid axis.

Authors:  G N Burrow; S W Spaulding; R Donabedian; M Van Woert; L Ambani
Journal:  Adv Neurol       Date:  1974

5.  Letter: Bromocriptine in parkinsonism.

Authors:  A G Debono; I Donaldson; C D Marsden; J D Parkes
Journal:  Lancet       Date:  1975-11-15       Impact factor: 79.321

6.  L-DOPA suppression of thyrotropin-releasing hormone response in man.

Authors:  S W Spaulding; G N Burrow; R Donabedian; M van Woert
Journal:  J Clin Endocrinol Metab       Date:  1972-07       Impact factor: 5.958

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  The hypothalamus in Parkinson disease.

Authors:  J W Langston; L S Forno
Journal:  Ann Neurol       Date:  1978-02       Impact factor: 10.422

9.  Evaluation of Prl secretion in elderly subjects.

Authors:  E Rolandi; G Magnani; A Sannia; T Barreca
Journal:  Acta Endocrinol (Copenh)       Date:  1982-07

10.  Growth hormone responses to L-dopa in depressed patients.

Authors:  E J Sachar; G Mushrush; M Perlow; E D Weitzman; J Sassin
Journal:  Science       Date:  1972-12-22       Impact factor: 47.728

View more
  4 in total

1.  Acute levodopa administration reduces cortisol release in patients with Parkinson's disease.

Authors:  T Müller; J Welnic; S Muhlack
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

2.  The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.

Authors:  Caitlin M Daimon; Patrick Chirdon; Stuart Maudsley; Bronwen Martin
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013

3.  Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson's disease.

Authors:  G Bellomo; L Santambrogio; M Fiacconi; A M Scarponi; G Ciuffetti
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

4.  Cortisol levels, motor, cognitive and behavioral symptoms in Parkinson's disease: a systematic review.

Authors:  Nayron Medeiros Soares; Gabriela Magalhães Pereira; Vivian Altmann; Rosa Maria Martins de Almeida; Carlos R M Rieder
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.